A Non-inferiority Randomized Control Trial Comparing Two Calcium Silicate-based Cements as Pulp Capping Material for Partial Pulpotomy in Permanent Teeth with Cariously Exposed Pulp in Adult Patients
Article Sidebar
Main Article Content
Abstract
ProRoot® MTA is a conventional calcium silicate-based cement which has been widely used as a pulp capping material owing to its distinctly high biocompatibility and clinical success. However, it poses some known disadvantages such as high cost and tooth discoloration potential. Biodentine™ is a new calcium silicate–based cement which has revised the disadvantages of ProRoot® MTA. Currently, there is limited clinical evidence of partial pulpotomy using Biodentine™. The purpose of the present study is to investigate the outcomes of partial pulpotomy using Biodentine™ as a pulp capping material compared to that of ProRoot® MTA in adults with carious exposure. A non-inferiority randomized trial design with a prestated margin of 10% difference was implemented. Fifty-eight (58) teeth with carious pulp exposures were randomly assigned to either the ProRoot® MTA or the Biodentine™ group. Partial pulpotomy was performed. Patients were asked to report the post-operative symptoms at 24 hours, 7 days and 3 months. Patients were recalled at the first mean follow-up time of 6.23±0.79 months and the secondary mean follow-up time of 12.45±1.17 months there were 2 out of 58 participants loss to follow-up. The overall success rate was 96.4% with 92.6% for ProRoot® MTA and 100% for Biodentine™ (difference, -7.4%; 95% CI, -7.3% to 2.47%, P=0.14). At 24 hours after treatment, most patients experienced mild pain or sensitivity. Most patients get better in 7 days and all became symptom-free within 3 months. Perceptible gray discoloration was observed in only ProRoot® MTA group with significant difference (p=0.02) to Biodentine™ group. These favorable outcomes suggested that partial pulpotomy in adults’ teeth using Biodentine™ was non-inferior to ProRoot® MTA at the mean 12.45±1.17 - month period. Biodentine™ may be used as an alternative to ProRoot® MTA.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความ ข้อมูล เนื้อหา รูปภาพ ฯลฯ ที่ได้รับการลงตีพิมพ์ในวิทยาสารทันตแพทยศาสตร์ มหาวิทยาลัยขอนแก่นถือเป็นลิขสิทธิ์เฉพาะของคณะทันตแพทยศาสตร์ มหาวิทยาลัยขอนแก่น หากบุคคลหรือหน่วยงานใดต้องการนำทั้งหมดหรือส่วนหนึ่งส่วนใดไปเผยแพร่ต่อหรือเพื่อกระทำการใด ๆ จะต้องได้รับอนุญาตเป็นลายลักษณ์อักษร จากคณะทันตแพทยศาสตร์ มหาวิทยาลัยขอนแก่นก่อนเท่านั้น
References
American Association of Endodontists (AAE), Endodontics Colleagues for Excellence, Endodontic diagnosis [Internet]. Chicago: American Association of Endodontists; c1997 [revised 2013; cited 2020 Aug 9]. Avialable from: https:// www.aae.org/ specialty/ newsletter/endodontic-diagnosis/.
Burry C, Stover S, Eichmiller F, Bhagavatula P. Outcomes of primary endodontic therapy provided by endodontic specialists compared with other providers. J Endod 2016;42(5):702-5.
European Society of Endodontology (ESE) developed by: Duncan F, Galler M, Tomson L, Simon S, El-Karim I, Kundzina R et al. European Society of Endodontology position statement: Management of deep caries and the exposed pulp. Int Endod J 2019 Jul;52(7):923-34.
Yazdani S, Jadidfard P, Tahani B, Kazemian A, Dianat O, Marvasti A. Health technology assessment of CEM pulpotomy in permanent molars with irreversible pulpitis. Iran Endod J 2014;9(1):23.
Aguilar P, Linsuwanont P. Vital pulp therapy in vital permanent teeth with cariously exposed pulp: a systematic review. J Endod 2011;37(5): 581-7.
Ward J. Vital pulp therapy in cariously exposed permanent teeth and its limitations. Aust Endod J 2002;28(1):29-37.
American Academy of Pediatric Dentistry. Guideline on pulp therapy for primary and immature permanent teeth. Pediatr Dent. 2017; 38(6):280-8.
Iezzi I, Pagella P, Mattioli-Belmonte M, Mitsiadis T. The effects of ageing on dental pulp stem cells, the tooth longevity elixir. Eur Cell Mater 2019;26:175-85.
Nowicka A, Lipski M, Parafiniuk M, Sporniak-Tutak K, Lichota D, Kosierkiewicz A, et al. Response of human dental pulp capped with biodentine and mineral trioxide aggregate. J Endod 2013;36(9): 743-7.
Tran V, Gorin C, Willig C, Baroukh B, Pellat B, Decup F, et al. Effect of a calcium-silicate-based restorative cement on pulp repair. J Dent Res 2012;91(2):1166.
Laurent P, Camps J, De Meo M, Dejou J, About I. Induction of specific cell responses to a Ca3SiO5-based posterior restorative material. Dent Mater 2008;24(11):1486-94.
Chailertvanitkul P, Paphangkorakit J, Sooksanti sakoonchai N, Pumas N, Pairojamornyoot W, Leela-Apiradee N, et al. Randomized control trial comparing calcium hydroxide and mineral trioxide aggregate for partial pulpotomies in cariously exposed pulps of permanent molars. Int Endod J 2014;47(9):835-42.
Kundzina R, Stangvaltaite L, Eriksen M, Kerosuo E. Capping carious exposures in adults: a randomized controlled trial investigating mineral trioxide aggregate versus calcium hydroxide. Int Endod J 2017;50(10):924-32.
Orstavik D, Kerekes K, Eriksen M. The periapical index: a scoring system for radiographic assessment of apical periodontitis. Endod Dent Traumatol 1986;2(1):20-34.
Kunert G, Kunert R, da Costa Filho C, de Figueiredo P. Permanent teeth pulpotomy survival analysis: retrospective follow-up. J Dent 2015;43:1125-31.
Tan Y, Yu H, Lim C, Tan K, Neo J, Shen L, et al. Long-term pulpal and restorative outcomes of pulpotomy in mature permanent teeth. J Endod 2020;46(3):383-90.
Taha N, Khazali A. Partial pulpotomy in mature permanent teeth with clinical signs indicative of irreversible pulpitis: a randomized clinical trial. J Endod 2017;43(9):1417-21.
Uesrichai N, Nirunsittirat A, Chuveera P, Srisuwan T, Sastraruji T, Chompu-inwai P. Partial pulpotomy with two bioactive cements in permanent teeth of 6-to 18-year-old patients with signs and symptoms indicative of irreversible pulpitis: a noninferiority randomized controlled trial. Int Endod J 2019;52(6):749-59.
Parirokh M, Torabinejad M. Mineral trioxide aggregate: a comprehensive literature review-part III: clinical applications, drawbacks, and mechanism of action. J Endod 2010;36(3):400-13.
Barrieshi-Nusair M, Qudeimat A. A prospective clinical study of mineral trioxide aggregate for partial pulpotomy in cariously exposed permanent teeth. J Endod 2006;32(8):731-5.
Qudeimat M, Alyahya A, Hasan A, Barrieshi‐Nusair K. Mineral trioxide aggregate pulpotomy for permanent molars with clinical signs indicative of irreversible pulpitis: a preliminary study. Int Endod J 2017;50(2):126-34.
Barthel R, Rosenkranz B, Leuenberg A, Roulet F. Pulp capping of carious exposures: treatment outcome after 5 and 10 years: a retrospective study. J Endod 2000;26(9):525-8.
Matsuo T, Nakanishi T, Shimizu H, Ebisu S. A clinical study of direct pulp capping applied to carious-exposed pulps. J Endod 1996;22(10):551-6.
Bogen G, Kim S, Bakland K. Direct pulp capping with mineral trioxide aggregate: an observational study. J Am Dent Assoc 2008;139(3):305-15.
Mass E, Zilberman U. Clinical and radiographic evaluation of partial pulpotomy in carious exposure of permanent molars. Pediatr Dent 1993;15:257-9.
Mente J, Geletneky B, Ohle M, Koch J, Friedrich Ding G, Wolff D, et al. Mineral trioxide aggregate or calcium hydroxide direct pulp capping: an analysis of the clinical treatment outcome. J Endod 2010;36(5):806–13.
Linsuwanont P, Wimonsutthikul K, Pothimoke U, Santiwong B. Treatment outcomes of mineral trioxide aggregate pulpotomy in vital permanent teeth with carious pulp Exposure: the retrospective study. J Endod 2017;43(2):225-30.
Mutluay M, Arikan V, Sari S, Kisa U. Does achievement of hemostasis after pulp exposure provide an accurate assessment of pulp inflammation? Pediatr Dent 2018;40(1):37-42.
Elsalhy M, Azizieh F, Raghupathy R. Cytokines as diagnostic markers of pulpal inflammation. Int Endod J 2013;46(6):573-80.
Shokouhinejad N, Nekoofar H, Pirmoazen S, Shamshiri R, Dummer M. Evaluation and comparison of occurrence of tooth discoloration after the application of various calcium silicate–based cements: an ex vivo study. J Endod 2016;42(1):140-4.
Valles M, Roig M, Duran-Sindreu F, Martinez S, Mercade M. Color stability of teeth restored with Biodentine: a 6-month in vitro study. J Endod 2015;41(7):1157-60.
Mozynska J, Metlerski M, Lipski M, Nowicka A. Tooth discoloration induced by different calcium silicate–based cements: A systematic review of in vitro studies. J Endod 2017;43(10):1593-601.
Carvalho T, Lussi A. Age‐related morphological, histological and functional changes in teeth. J Oral Rehabil 2017;44(4):291-8.
Camilleri J. Staining potential of Neo MTA Plus, MTA Plus, and Biodentine used for pulpotomy procedures. J Endod 2015;41(7):1139-45.